$WNDW
SolarWindow Technologies, Inc.

2022 Q3 Form 10-Q Financial Statement

#000117184322004900 Filed on July 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $639.3K $776.7K $1.136M
YoY Change -41.81% -44.32% -36.4%
% of Gross Profit
Research & Development $290.0K $191.4K $243.1K
YoY Change -8.91% -54.83%
% of Gross Profit
Depreciation & Amortization $11.15K $3.057K $7.170K
YoY Change 81.3% -66.71% 7.34%
% of Gross Profit
Operating Expenses $929.3K $968.1K $1.379M
YoY Change -34.41% -46.77% -35.93%
Operating Profit -$968.1K -$1.178M
YoY Change -46.77%
Interest Expense $27.21K $5.860K $1.240K
YoY Change 1529.34% -52.89% -62.2%
% of Operating Profit
Other Income/Expense, Net $674.2K -$668.3K $0.00
YoY Change -5474.66%
Pretax Income -$608.1K -$1.636M -$1.378M
YoY Change -57.03% -9.41% -35.89%
Income Tax
% Of Pretax Income
Net Earnings -$608.1K -$1.636M -$1.378M
YoY Change -57.03% -9.41% -35.89%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.03
Diluted Earnings Per Share -$0.01 -$30.76K -$25.90K
COMMON SHARES
Basic Shares Outstanding 53.20M shares 53.20M shares 53.20M shares
Diluted Shares Outstanding 26.06M shares 53.20M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.078M $8.633M $9.371M
YoY Change -33.39% -32.96% -30.47%
Cash & Equivalents $8.078M $8.632M $9.371M
Short-Term Investments $0.00 $0.00 $0.00
Other Short-Term Assets $284.6K $247.0K $348.7K
YoY Change 49.04% -26.56% -32.49%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.362M $8.879M $9.720M
YoY Change -32.11% -32.8% -30.54%
LONG-TERM ASSETS
Property, Plant & Equipment $1.330M $1.327M $1.949M
YoY Change -4.13% -3.11% 39.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $20.77K
YoY Change -100.0% -100.0% 46.37%
Total Long-Term Assets $1.330M $1.327M $1.969M
YoY Change -5.6% -4.68% 39.48%
TOTAL ASSETS
Total Short-Term Assets $8.362M $8.879M $9.720M
Total Long-Term Assets $1.330M $1.327M $1.969M
Total Assets $9.692M $10.21M $11.69M
YoY Change -29.39% -30.12% -24.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $118.4K $43.39K $134.9K
YoY Change 113.68% -68.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $118.4K $72.97K $165.0K
YoY Change -30.43% -64.29% 50.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $118.4K $72.97K $165.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $118.4K $72.97K $165.0K
YoY Change -30.43% -64.29% 50.31%
SHAREHOLDERS EQUITY
Retained Earnings -$72.98M -$72.37M
YoY Change 7.27%
Common Stock $53.20K $53.20K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.574M $10.13M $11.52M
YoY Change
Total Liabilities & Shareholders Equity $9.692M $10.21M $11.69M
YoY Change -29.39% -30.12% -24.12%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$608.1K -$1.636M -$1.378M
YoY Change -57.03% -9.41% -35.89%
Depreciation, Depletion And Amortization $11.15K $3.057K $7.170K
YoY Change 81.3% -66.71% 7.34%
Cash From Operating Activities -$762.0K -$717.6K -$1.436M
YoY Change 6.62% 14.33% 94.65%
INVESTING ACTIVITIES
Capital Expenditures -$244.6K -$17.36K -$581.1K
YoY Change 944.53% -192.69% 1223.09%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $244.6K -$17.37K -$581.1K
YoY Change -1144.53% -192.74% 1223.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -762.0K -717.6K -1.436M
Cash From Investing Activities 244.6K -17.37K -581.1K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -517.3K -735.0K -2.017M
YoY Change -29.38% 20.7% 3144.71%
FREE CASH FLOW
Cash From Operating Activities -$762.0K -$717.6K -$1.436M
Capital Expenditures -$244.6K -$17.36K -$581.1K
Free Cash Flow -$517.3K -$700.2K -$854.7K
YoY Change -25.15% 8.33% 23.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
usd
CY2021Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.16
us-gaap Other Income
OtherIncome
usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2022Q2 us-gaap Other Income
OtherIncome
usd
CY2021Q2 us-gaap Other Income
OtherIncome
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001071840
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2022Q2 us-gaap Deposits Assets
DepositsAssets
usd
wndw Increase Decrease Operating In Lease Assets And Liabilities
IncreaseDecreaseOperatingInLeaseAssetsAndLiabilities
usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
wndw Redemption Of Shortterm Investments
RedemptionOfShorttermInvestments
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
333-127953
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43391 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
55402 usd
dei Entity Registrant Name
EntityRegistrantName
SOLARWINDOW TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3509694
dei Entity Address Address Line1
EntityAddressAddressLine1
9375 E. Shea Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 107-B
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
213-0689
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53198399 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8632495 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7127456 usd
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
5000000 usd
CY2022Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
130970 usd
CY2021Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
122332 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
115975 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68649 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
8879440 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
12318437 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114030 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110271 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1327195 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1387342 usd
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
21598 usd
CY2022Q2 us-gaap Assets
Assets
10206635 usd
CY2021Q3 us-gaap Assets
Assets
13727377 usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
29583 usd
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
114750 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
72974 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
170152 usd
CY2022Q2 us-gaap Liabilities
Liabilities
72974 usd
CY2021Q3 us-gaap Liabilities
Liabilities
170152 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Share Based Compensation
ShareBasedCompensation
902007 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4205634 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53198399 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
53198 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82453847 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81551840 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14872 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72373384 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68032941 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10133661 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
13557225 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10206635 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13727377 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
776707 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1394977 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2900575 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5180785 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
191439 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
423859 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
797295 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1338248 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
968146 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1818836 usd
us-gaap Operating Expenses
OperatingExpenses
3697870 usd
us-gaap Operating Expenses
OperatingExpenses
6519033 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-968146 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1818836 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3697870 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6519033 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5861 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12435 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18066 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35102 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-8775 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
674200 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
674200 usd
us-gaap Other Income
OtherIncome
13560 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-668339 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12435 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-642574 usd
us-gaap Net Income Loss
NetIncomeLoss
-6492706 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
278863 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5160 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-1326124 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12504804 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410789 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13696 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1377834 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26327 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636485 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11524063 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
212355 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1806401 usd
us-gaap Net Income Loss
NetIncomeLoss
-4340444 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33728 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1636485 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10133661 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
15967129 usd
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1838532 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8775 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-33728 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-8014 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-14872 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1247 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1602757 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1798387 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4325572 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6491459 usd
CY2022Q2 wndw Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.03
CY2021Q2 wndw Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.03
wndw Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.08
wndw Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.12
CY2022Q2 wndw Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
53198399 shares
CY2021Q2 wndw Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
53196799 shares
wndw Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
53198399 shares
wndw Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
53076883 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
13557225 usd
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3277 usd
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-2537035 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15271903 usd
CY2021Q1 wndw Exercise Of Warrants
ExerciseOfWarrants
684000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35400 usd
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1463904 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10044 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2149270 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
15295893 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
903198 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8014 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1806401 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
14400704 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
20142 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
674200 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4340444 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6492706 usd
CY2022Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
674200 usd
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8632495 usd
us-gaap Depreciation
Depreciation
18865 usd
us-gaap Depreciation
Depreciation
21637 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92363 usd
CY2022Q2 wndw Working Capital
WorkingCapital
8806466 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
8638 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-386975 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
48699 usd
CY2022Q2 wndw Domestic Bank Accounts
DomesticBankAccounts
1192917 usd
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
7439578 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-19906 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11102 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
85338 usd
wndw Increase Decrease Operating In Lease Assets And Liabilities
IncreaseDecreaseOperatingInLeaseAssetsAndLiabilities
353 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-85167 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-47636 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2878836 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1944605 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5000000 usd
wndw Redemption Of Shortterm Investments
RedemptionOfShorttermInvestments
-5000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
601598 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
52920 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2161 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4398402 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5050759 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
719400 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
719400 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14527 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
887 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1505039 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6275077 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7127456 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14151523 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8632495 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7876446 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636485 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1806401 usd
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19283517 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19281917 shares
CY2022Q2 us-gaap Cash
Cash
8632495 usd
CY2021Q3 us-gaap Cash
Cash
7127456 usd
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
5000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8632495 usd
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
12127456 usd
us-gaap Net Income Loss
NetIncomeLoss
-4340444 usd
us-gaap Net Income Loss
NetIncomeLoss
-6492706 usd
CY2022Q2 wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53198399 shares
CY2021Q2 wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53196799 shares
wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53198399 shares
wndw Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
53076883 shares
CY2022Q2 wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.03
CY2021Q2 wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.03
wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.08
wndw Basic And Diluted Eps Computation
BasicAndDilutedEpsComputation
-0.12
CY2022Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6781800 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6740400 shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6781800 shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
6740400 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19281917 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
19283517 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26063717 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26023917 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26063717 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26023917 shares
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1441225 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1497613 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
114030 usd
CY2021Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
110271 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1327195 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1387342 usd
CY2022Q2 us-gaap Depreciation
Depreciation
3057 usd
CY2021Q2 us-gaap Depreciation
Depreciation
9183 usd
us-gaap Depreciation
Depreciation
18865 usd
us-gaap Depreciation
Depreciation
21637 usd
CY2019 wndw Estimated Cost
EstimatedCost
1803000 usd
CY2022Q1 us-gaap Payments For Deposits
PaymentsForDeposits
581000 usd
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53198399 shares
CY2022Q2 wndw Shares Of Common Stock Issuable From Warrants
SharesOfCommonStockIssuableFromWarrants
19281917 shares
CY2021Q3 wndw Shares Of Common Stock Issuable From Warrants
SharesOfCommonStockIssuableFromWarrants
19281917 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0331 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8944 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0019 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
wndw Options Outstanding
OptionsOutstanding
2653000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.63
CY2022Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
191122 usd
CY2021Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
761654 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
838309 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
3617132 usd
CY2022Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
21233 usd
CY2021Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
141544 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
63698 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
588502 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
212355 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
903198 usd
us-gaap Share Based Compensation
ShareBasedCompensation
902007 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4205634 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M9D
wndw Rent Description
RentDescription
The apartment lease provided for a term of one year beginning March 7, 2021, and was renewed on March 7, 2022 for an additional year. Monthly rent is approximately $950. The Company paid a security deposit of approximately $8,700.

Files In Submission

Name View Source Status
0001171843-22-004900-index-headers.html Edgar Link pending
0001171843-22-004900-index.html Edgar Link pending
0001171843-22-004900.txt Edgar Link pending
0001171843-22-004900-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_071222p.htm Edgar Link pending
f10q_071222p_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wndw-20220531.xsd Edgar Link pending
wndw-20220531_cal.xml Edgar Link unprocessable
wndw-20220531_def.xml Edgar Link unprocessable
wndw-20220531_lab.xml Edgar Link unprocessable
wndw-20220531_pre.xml Edgar Link unprocessable